指南与共识胸部肿瘤

Ⅳ期非小细胞肺癌伴驱动基因改变的ASCO动态指南2026.3.4版

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4.
指南 / 共识 · J Clin Oncol · 2026-10-29

该ASCO动态指南针对Ⅳ期伴驱动基因改变的非小细胞肺癌的治疗,由常设专家组持续系统检索并定期更新推荐。原文正文与摘要未提供具体推荐条款、疗效数值或证据等级,仅说明更新机制与免责声明。

要点

  • 适用于Ⅳ期伴驱动基因改变的非小细胞肺癌的治疗决策。
  • 由常设专家组持续系统检索文献并定期更新推荐。
  • 本版本未呈现具体推荐内容与疗效数据。

核心结论

  • 该动态指南针对Ⅳ期伴驱动基因改变的非小细胞肺癌治疗,按计划定期更新推荐。

研究设计与样本

  • ASCO动态指南,由常设专家组按ASCO指南方法学手册持续系统检索健康文献并定期更新,遵循ASCO利益冲突政策。

临床怎么用

  • 可作为Ⅳ期伴驱动基因改变非小细胞肺癌治疗推荐的动态参考,具体条款需查阅正式发布的完整版本。

局限性

  • 原文正文与摘要未提供具体推荐、疗效数值与证据等级。
  • 动态指南不替代临床医生的独立专业判断,也未考虑患者个体差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

[Box: see text]Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Reuss, Ismaila, Doroshow, et al. Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4. J Clin Oncol. 2026. PMID: 42956324. doi:10.1200/JCO-26-02597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。